News >

Liquid Biopsies Reliably and Quickly Detect Genomic Biomarkers in Metastatic NSCLC

Kristi Rosa
Published: Tuesday, Apr 16, 2019

Vassiliki A. Papadimitrakopoulou, MD
Vassiliki A.
Papadimitrakopoulou, MD
Liquid biopsies can reliably detect guideline-recommended biomarkers in patients with stage IV non–small cell lung cancer (NSCLC), said Vassiliki A. Papadimitrakopoulou, MD, with a quicker turnaround time compared with that of standard tissue-based assays.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication